Mapping the COVID-19 T-cell response at a single-cell level

Understanding COVID-19 immune response

While most COVID-19 patients are asymptomatic or display mild symptoms, some patients develop severe clinical symptoms. The pathogenic basis for this difference in disease severity among patients is poorly understood. Developing a better understanding of immune response across patient populations is crucial to understanding these differences, and to the development of future vaccines capable of targeting novel COVID-19 variants.

This webinar will present cutting edge research and provide insights from the intersection between three areas of intense current focus – COVID-19 clinical research, single cell analysis and the measurement of T-cell response.

Attendees will leave with new approaches and ideas for achieving in-depth characterization of the CD8+ T-cell-mediated response to COVID-19 infection, which will support (1) the development of better molecular and targeted therapies, and (2) the development of better vaccination strategies.

This webinar consists of 2 presentations, followed by a Q&A session.

---

Talk 1: Dissecting CD8+ T-cell pathology of severe SARS-CoV-2 infection by single-cell epitope mapping

Felix Schreibing, MD, Postdoctoral Fellow, Institute of Experimental Medicine and Systems Biology. University Hospital RWTH Aachen

Talk 2: dCODE Dextramer® – Unravelling the specificity of T-cell immunity

Matilda Felicia Weywadt, Ph.D., Product Manager, Immudex

Q&A with:

– Felix Schreibing, MD, Postdoctoral Fellow, Institute of Experimental Medicine and Systems Biology. University Hospital RWTH Aachen
– Matilda Felicia Weywadt, Ph.D., Product Manager, Immudex
– Monica Hannini, Ph.D. Fellow, Institute of Experimental Medicine and Systems Biology, University Hospital RWTH Aachen

---

This webinar has been made possible with the kind support of our partner, Immudex. To find out more about the dCODE Dextramer® technology, visit the Immudex website.

Register for the webinar